Amprenavir - CISMeF

Preferred Label : Amprenavir;

NCIt synonyms : Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(- phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-;

NCIt definition : A synthetic derivative of hydroxyethylamine sulfonamide that selectively binds to and inhibits human immunodeficiency virus (HIV) protease.;

UNII : 5S0W860XNR;

InChIKey : YMARZQAQMVYCKC-OEMFJLHTSA-N;

CAS number : 161814-49-9;

Drug name : Agenerase;

Molecule name : KVX 478; 141W94; VX 478;

Chemical formula : C25H35N3O6S;

ChEBI ID : CHEBI:40050;

Détails

Origin ID

C28824;

UMLS CUI

C0754188;

See also inter- (CISMeF)
- Product containing amprenavir (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Amprenavir [LOINC component]
- Amprenavir (substance) [SNOMED CT concept]
- Product containing amprenavir (medicinal product) [SNOMED CT concept]
- amprenavir [ATC Code]
- amprenavir [MeSH Supplementary Concept]
- amprenavir [MeSH concept]
Validated automatic mappings to BTNT
- amprenavir [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Amprenavir Mesylate [NCIt concept]
is_free_acid_or_base_form_of
- Amprenavir Mesylate [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients